Immunotherapy successfully fights leukemia in relapsed patient

07/11/2013 |

A relapsed leukemia patient taking part in the cellular immunotherapy Phase I cancer trial at Seattle Children's Hospital was deemed free of leukemia cells after about seven months of treatment. The trial is testing the effectiveness of modifying the function of T-cells from the patient's own blood so that they attack the cancer cells. Findings showed that the patient "has had a positive response to the T-cell therapy and, at this time, we do not detect any leukemia cells," lead investigator Dr. Rebecca Gardner said.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Chief Medical Officer
Nashville, TN
Commercial Health Insurance Strategist__Job #52-14
American Academy of Family Physicians
Leawood, KS
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC